Cargando…
Novel mutations in response to vitamin B6 in primary hyperoxaluria type 1 after only kidney transplantation: a case report
Recently, the mainstream curative treatment for primary hyperoxaluria type 1 (PH1) is combined liver and kidney transplantation, and only kidney transplantation is considered ineffective for most PH1 patients. Furthermore, vitamin B6 (B6) is the only permitted drug available for treatment. However,...
Autores principales: | Zhao, Yuanyuan, Yang, Yang, Zhou, Ping, Jiang, Jipin, Chen, Zhishui, Du, Dunfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807321/ https://www.ncbi.nlm.nih.gov/pubmed/33457257 http://dx.doi.org/10.21037/tau-20-979 |
Ejemplares similares
-
Value of blood lipid in predicting graft dysfunction after organ and tissue transplantation: A study of Mendelian randomization
por: Zhao, Yuanyuan, et al.
Publicado: (2023) -
A Case Report of Kidney-Only Transplantation in Primary Hyperoxaluria Type 1: A Novel Approach with the Use of Nedosiran
por: Breeggemann, Matthew C., et al.
Publicado: (2023) -
Determinants of Kidney Failure in Primary Hyperoxaluria Type 1: Findings of the European Hyperoxaluria Consortium
por: Metry, Elisabeth L., et al.
Publicado: (2023) -
Recurrence of crystalline nephropathy after kidney transplantation in APRT deficiency and primary hyperoxaluria
por: Bollée, Guillaume, et al.
Publicado: (2015) -
Primary Hyperoxaluria
por: Harambat, Jérôme, et al.
Publicado: (2011)